While medical headlines often focus on the biochemical underpinnings of disease, our body's biomechanics are equally crucial.

She was born with a congenital heart defect, an Atrial Septal Defect, ASD, commonly known as a “hole in the heart” that ...

November is Pulmonary Hypertension Awareness Month, and George Washington University Hospital’s Doctor Mardi Gomberg-Maitland ...

The study demonstrates that activating the vitamin D receptor (VDR) with calcitriol suppresses cell proliferation in ...

Pulmonary hypertension (PH) is a condition that occurs when your blood pressure in the blood vessels between the heart and lungs is abnormally high. Blood pressure measures the amount of force it ...

Pulmonary arterial hypertension (PAH) is one of five types of pulmonary hypertension. It happens when the blood vessels in your lungs narrow and scar so much that it’s hard for blood to move ...

"Pulmonary hypertension usually affects people aged 30 to 60. Its early signs and symptoms can mimic those of various other ...

Background: The use of appetite suppressants in Europe has been associated with the development of primary pulmonary hypertension (PPH). Recently, fenfluramine appetite suppressants became widely ...

Therapies that target the prostacyclin pathway hold promise as chronic CTEPH treatment, a meta-analysis of controlled trials ...

Most patients with pulmonary arterial hypertension (PAH) suffered from poor sleep quality, and dyspnea was a significant ...

Daniel Martin speaks with Professor Edmund Lau, lung specialist from Royal Prince Alfred Hospital and Professor of Medicine ...